Evidence map›Paper›PMID 30787191›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Podocalyxin is required for maintaining blood-brain barrier function during acute inflammation.

Jessica Cait, Michael R Hughes, Matthew R Zeglinski, Allen W Chan, Sabrina Osterhof, R Wilder Scott, Diana Canals Hernaez, Alissa Cait, A Wayne Vogl, Pascal Bernatchez and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Gene-Specific Endothelial Programs Drive AVM Pathogenesis inArteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Materials today. Bio · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Jessica CaitBiomedical Research Centre, University of British Columbia, Vancouver, BC, Canada V6T 1Z3.
Michael R HughesBiomedical Research Centre, University of British Columbia, Vancouver, BC, Canada V6T 1Z3; mhughes@brc.ubc.ca kelly@brc.ubc.ca.
Matthew R ZeglinskiICORD Centre, University of British Columbia, Vancouver, BC, Canada V5Z 1M9.ORCID 0000-0002-3858-5791
Allen W ChanDepartment of Psychiatry, University of British Columbia, Vancouver, BC, Canada V6T 2A1.
Sabrina OsterhofBiomedical Research Centre, University of British Columbia, Vancouver, BC, Canada V6T 1Z3.
R Wilder ScottBiomedical Research Centre, University of British Columbia, Vancouver, BC, Canada V6T 1Z3.
Diana Canals HernaezBiomedical Research Centre, University of British Columbia, Vancouver, BC, Canada V6T 1Z3.
Alissa CaitBiomedical Research Centre, University of British Columbia, Vancouver, BC, Canada V6T 1Z3.
A Wayne VoglDepartment of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada V6T 1Z4.
Pascal BernatchezCentre for Heart and Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada V6Z 1Y6.
T Michael UnderhillBiomedical Research Centre, University of British Columbia, Vancouver, BC, Canada V6T 1Z3.
David J GranvilleICORD Centre, University of British Columbia, Vancouver, BC, Canada V5Z 1M9.
Timothy H MurphyDepartment of Psychiatry, University of British Columbia, Vancouver, BC, Canada V6T 2A1.
Calvin D RoskelleyDepartment of Cellular and Physiological Sciences, University of British Columbia, Vancouver, BC, Canada V6T 1Z4.
Kelly M McNagnyBiomedical Research Centre, University of British Columbia, Vancouver, BC, Canada V6T 1Z3; mhughes@brc.ubc.ca kelly@brc.ubc.ca.ORCID 0000-0003-4737-3499
University of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Podocalyxin (Podxl) is broadly expressed on the luminal face of most blood vessels in adult vertebrates, yet its function on these cells is poorly defined. In the present study, we identified specific functions for Podxl in maintaining endothelial barrier function. Using electrical cell substrate impedance sensing and live imaging, we found that, in the absence of Podxl, human umbilical vein endothelial cells fail to form an efficient barrier when plated on several extracellular matrix substrates. In addition, these monolayers lack adherens junctions and focal adhesions and display a disorganized cortical actin cytoskeleton. Thus, Podxl has a key role in promoting the appropriate endothelial morphogenesis required to form functional barriers. This conclusion is further supported by analyses of mutant mice in which we conditionally deleted a floxed allele of

Indexed as

Blood-Brain BarrierEndothelial CellsHumansHuman Umbilical Vein Endothelial CellsInflammationMorphogenesisSialoglycoproteinspodocalyxinSialoglycoproteinsbarrier functionblood–brain barrierCD34 familyendothelialpodocalyxin

Identifiers

PMID30787191
PMCPMC6410846
OpenAlexW2917043336

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.